nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolazoline—Amphetamine—SLC22A5—Crohn's disease	0.0175	0.519	CrCbGaD
Tolazoline—Methamphetamine—SLC22A5—Crohn's disease	0.0162	0.481	CrCbGaD
Tolazoline—ADRA2A—Metabolism—PLA2G4F—Crohn's disease	0.00128	0.00132	CbGpPWpGaD
Tolazoline—HRH2—GPCR ligand binding—CXCL8—Crohn's disease	0.00128	0.00132	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—GPR65—Crohn's disease	0.00128	0.00132	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00127	0.00132	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—MLN—Crohn's disease	0.00126	0.0013	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00125	0.00129	CbGpPWpGaD
Tolazoline—ADRA2B—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00124	0.00129	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—ACKR2—Crohn's disease	0.00123	0.00128	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—CCR6—Crohn's disease	0.00123	0.00128	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—RSPO3—Crohn's disease	0.00123	0.00127	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—ITGA4—Crohn's disease	0.00122	0.00126	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00122	0.00126	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CCR6—Crohn's disease	0.0012	0.00125	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CCR6—Crohn's disease	0.0012	0.00124	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00119	0.00124	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—IL3—Crohn's disease	0.00119	0.00123	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—IL2RA—Crohn's disease	0.00118	0.00122	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TAGAP—Crohn's disease	0.00117	0.00121	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—MLN—Crohn's disease	0.00117	0.00121	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SEL1L—Crohn's disease	0.00117	0.00121	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—ALB—Crohn's disease	0.00117	0.00121	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—PTGER4—Crohn's disease	0.00116	0.0012	CbGpPWpGaD
Tolazoline—ADRA2C—G alpha (i) signalling events—CXCL8—Crohn's disease	0.00116	0.0012	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TAGAP—Crohn's disease	0.00115	0.00119	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RSPO3—Crohn's disease	0.00115	0.00119	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—RASGRP1—Crohn's disease	0.00115	0.00119	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CCR6—Crohn's disease	0.00112	0.00116	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—CCR6—Crohn's disease	0.0011	0.00114	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—IL2RA—Crohn's disease	0.0011	0.00113	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SEL1L—Crohn's disease	0.00109	0.00113	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—RBX1—Crohn's disease	0.00109	0.00113	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—MTMR3—Crohn's disease	0.00109	0.00113	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—PTGER4—Crohn's disease	0.00108	0.00112	CbGpPWpGaD
Tolazoline—ADRA2A—Platelet activation, signaling and aggregation—JAK2—Crohn's disease	0.00108	0.00112	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CCR6—Crohn's disease	0.00108	0.00111	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—IL2RA—Crohn's disease	0.00107	0.00111	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TAGAP—Crohn's disease	0.00107	0.00111	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCR9—Crohn's disease	0.00107	0.00111	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—PTGER4—Crohn's disease	0.00106	0.0011	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—PTGER4—Crohn's disease	0.00105	0.00109	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—FADS1—Crohn's disease	0.00104	0.00108	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RSPO3—Crohn's disease	0.00103	0.00106	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—IL2RA—Crohn's disease	0.00102	0.00106	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RSPO3—Crohn's disease	0.00101	0.00104	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CCR6—Crohn's disease	0.001	0.00104	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCR9—Crohn's disease	0.000998	0.00103	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CCR6—Crohn's disease	0.000997	0.00103	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—GPR65—Crohn's disease	0.000993	0.00103	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—IL3—Crohn's disease	0.000989	0.00102	CbGpPWpGaD
Tolazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000988	0.00102	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—PTGER4—Crohn's disease	0.000985	0.00102	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CCR6—Crohn's disease	0.000978	0.00101	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—GPX4—Crohn's disease	0.000977	0.00101	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SEL1L—Crohn's disease	0.000972	0.00101	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000966	0.001	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000957	0.00099	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—UBE2D1—Crohn's disease	0.000954	0.000987	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SEL1L—Crohn's disease	0.000954	0.000987	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000948	0.000981	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—GCKR—Crohn's disease	0.000943	0.000976	CbGpPWpGaD
Tolazoline—ADRA2A—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000942	0.000975	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RSPO3—Crohn's disease	0.000935	0.000967	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—GPR65—Crohn's disease	0.000928	0.00096	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—RIPK2—Crohn's disease	0.000925	0.000957	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—IL3—Crohn's disease	0.000924	0.000956	CbGpPWpGaD
Tolazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000923	0.000955	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CCR6—Crohn's disease	0.000909	0.000941	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IL3—Crohn's disease	0.000902	0.000934	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—IL3—Crohn's disease	0.000898	0.00093	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000894	0.000925	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCR9—Crohn's disease	0.000889	0.00092	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SEL1L—Crohn's disease	0.000886	0.000917	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000881	0.000912	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—PTGER4—Crohn's disease	0.000878	0.000908	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—RASGRP1—Crohn's disease	0.000873	0.000903	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCR9—Crohn's disease	0.000872	0.000903	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—RASGRP1—Crohn's disease	0.000869	0.000899	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—PTGER4—Crohn's disease	0.000861	0.000891	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—FADS1—Crohn's disease	0.000847	0.000877	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—IL3—Crohn's disease	0.000839	0.000868	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—IL2RA—Crohn's disease	0.000832	0.000861	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—GPR65—Crohn's disease	0.000826	0.000855	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—IL3—Crohn's disease	0.000823	0.000852	CbGpPWpGaD
Tolazoline—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000822	0.000851	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—RASGRP1—Crohn's disease	0.000811	0.00084	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—GPR65—Crohn's disease	0.000811	0.000839	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCR9—Crohn's disease	0.00081	0.000839	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—IL3—Crohn's disease	0.000808	0.000836	CbGpPWpGaD
Tolazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000807	0.000835	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—PTGER4—Crohn's disease	0.0008	0.000828	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000796	0.000824	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GPX4—Crohn's disease	0.000793	0.000821	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—ALB—Crohn's disease	0.000793	0.00082	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—JAK2—Crohn's disease	0.000792	0.00082	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—SOCS1—Crohn's disease	0.000791	0.000818	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000781	0.000808	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—GCKR—Crohn's disease	0.000766	0.000793	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—TYK2—Crohn's disease	0.000754	0.00078	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—GPR65—Crohn's disease	0.000753	0.00078	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR ligand binding—CXCL8—Crohn's disease	0.000752	0.000778	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—IL3—Crohn's disease	0.00075	0.000777	CbGpPWpGaD
Tolazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000749	0.000776	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL3—Crohn's disease	0.000747	0.000774	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—ALB—Crohn's disease	0.00074	0.000766	CbGpPWpGaD
Tolazoline—ADRA2B—Hemostasis—JAK2—Crohn's disease	0.000737	0.000763	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL3—Crohn's disease	0.000733	0.000759	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000726	0.000751	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000723	0.000748	CbGpPWpGaD
Tolazoline—HRH2—GPCR downstream signaling—CXCL8—Crohn's disease	0.000723	0.000748	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—JAK2—Crohn's disease	0.000719	0.000744	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000709	0.000734	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CCR6—Crohn's disease	0.000708	0.000732	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR ligand binding—CXCL8—Crohn's disease	0.000703	0.000727	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—IL2RA—Crohn's disease	0.000693	0.000717	CbGpPWpGaD
Tolazoline—ADRA2C—Hemostasis—JAK2—Crohn's disease	0.000688	0.000712	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—SMAD3—Crohn's disease	0.000683	0.000706	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL3—Crohn's disease	0.000681	0.000705	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CCR6—Crohn's disease	0.000661	0.000684	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000659	0.000682	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—CXCL8—Crohn's disease	0.000656	0.000679	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—IL2RA—Crohn's disease	0.000647	0.00067	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—RBX1—Crohn's disease	0.00064	0.000662	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IL2RA—Crohn's disease	0.000632	0.000654	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—IL2RA—Crohn's disease	0.000629	0.000651	CbGpPWpGaD
Tolazoline—HRH1—GPCR ligand binding—CXCL8—Crohn's disease	0.000626	0.000648	CbGpPWpGaD
Tolazoline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000623	0.000645	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—PTGER4—Crohn's disease	0.000623	0.000645	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR ligand binding—CXCL8—Crohn's disease	0.000614	0.000636	CbGpPWpGaD
Tolazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000612	0.000633	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—ALB—Crohn's disease	0.000601	0.000622	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RBX1—Crohn's disease	0.000598	0.000619	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CCR6—Crohn's disease	0.000589	0.000609	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—IL2RA—Crohn's disease	0.000588	0.000608	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—PTGER4—Crohn's disease	0.000582	0.000602	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CCR6—Crohn's disease	0.000578	0.000598	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—IL2RA—Crohn's disease	0.000577	0.000597	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR ligand binding—CXCL8—Crohn's disease	0.000571	0.000591	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000566	0.000586	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—UBE2D1—Crohn's disease	0.000561	0.000581	CbGpPWpGaD
Tolazoline—ADRA2A—Hemostasis—JAK2—Crohn's disease	0.000559	0.000579	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—RIPK2—Crohn's disease	0.000544	0.000563	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CCR6—Crohn's disease	0.000537	0.000556	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RBX1—Crohn's disease	0.000532	0.000551	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL3—Crohn's disease	0.000531	0.000549	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000526	0.000544	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—UBE2D1—Crohn's disease	0.000524	0.000542	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL2RA—Crohn's disease	0.000524	0.000542	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RBX1—Crohn's disease	0.000523	0.000541	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—PTGER4—Crohn's disease	0.000518	0.000536	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL2RA—Crohn's disease	0.000514	0.000532	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—RASGRP1—Crohn's disease	0.000513	0.000531	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—PTGER4—Crohn's disease	0.000509	0.000526	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RIPK2—Crohn's disease	0.000508	0.000526	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL3—Crohn's disease	0.000496	0.000513	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RBX1—Crohn's disease	0.000485	0.000502	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—RASGRP1—Crohn's disease	0.000479	0.000496	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL2RA—Crohn's disease	0.000477	0.000494	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—PTGER4—Crohn's disease	0.000473	0.000489	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—UBE2D1—Crohn's disease	0.000467	0.000483	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—JAK2—Crohn's disease	0.000466	0.000482	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SOCS1—Crohn's disease	0.000465	0.000481	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—UBE2D1—Crohn's disease	0.000458	0.000474	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RIPK2—Crohn's disease	0.000453	0.000469	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—TYK2—Crohn's disease	0.000445	0.000461	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RIPK2—Crohn's disease	0.000444	0.00046	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—TYK2—Crohn's disease	0.000443	0.000459	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL3—Crohn's disease	0.000442	0.000457	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—JAK2—Crohn's disease	0.000435	0.00045	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SOCS1—Crohn's disease	0.000434	0.000449	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL3—Crohn's disease	0.000433	0.000448	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—RASGRP1—Crohn's disease	0.000427	0.000442	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—UBE2D1—Crohn's disease	0.000426	0.000441	CbGpPWpGaD
Tolazoline—ADRA2B—GPCR downstream signaling—CXCL8—Crohn's disease	0.000425	0.00044	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—JAK2—Crohn's disease	0.000425	0.00044	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—JAK2—Crohn's disease	0.000423	0.000438	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—RASGRP1—Crohn's disease	0.000419	0.000434	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—TYK2—Crohn's disease	0.000414	0.000429	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RIPK2—Crohn's disease	0.000413	0.000427	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL3—Crohn's disease	0.000403	0.000417	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—SMAD3—Crohn's disease	0.000401	0.000415	CbGpPWpGaD
Tolazoline—ADRA2C—GPCR downstream signaling—CXCL8—Crohn's disease	0.000397	0.000411	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—JAK2—Crohn's disease	0.000395	0.000409	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—RASGRP1—Crohn's disease	0.000389	0.000403	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—CXCL8—Crohn's disease	0.000388	0.000401	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—JAK2—Crohn's disease	0.000388	0.000401	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SOCS1—Crohn's disease	0.000387	0.0004	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—CXCL8—Crohn's disease	0.000386	0.000399	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—JAK2—Crohn's disease	0.00038	0.000394	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SOCS1—Crohn's disease	0.00038	0.000393	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—SMAD3—Crohn's disease	0.000375	0.000388	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL2RA—Crohn's disease	0.000372	0.000385	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—TYK2—Crohn's disease	0.000369	0.000382	CbGpPWpGaD
Tolazoline—HRH2—Signaling by GPCR—IL6—Crohn's disease	0.000369	0.000382	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—TYK2—Crohn's disease	0.000362	0.000375	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—CXCL8—Crohn's disease	0.000361	0.000373	CbGpPWpGaD
Tolazoline—HRH1—GPCR downstream signaling—CXCL8—Crohn's disease	0.000354	0.000366	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—JAK2—Crohn's disease	0.000353	0.000366	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SOCS1—Crohn's disease	0.000353	0.000365	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—JAK2—Crohn's disease	0.000352	0.000364	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL2RA—Crohn's disease	0.000347	0.000359	CbGpPWpGaD
Tolazoline—ADRA1A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000347	0.000359	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—JAK2—Crohn's disease	0.000345	0.000357	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—TYK2—Crohn's disease	0.000336	0.000348	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—SMAD3—Crohn's disease	0.000334	0.000346	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—SMAD3—Crohn's disease	0.000328	0.000339	CbGpPWpGaD
Tolazoline—ADRA2A—GPCR downstream signaling—CXCL8—Crohn's disease	0.000322	0.000334	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—CXCL8—Crohn's disease	0.000321	0.000332	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—JAK2—Crohn's disease	0.000321	0.000332	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—CXCL8—Crohn's disease	0.000315	0.000326	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—STAT3—Crohn's disease	0.000312	0.000323	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL2RA—Crohn's disease	0.000309	0.00032	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—SMAD3—Crohn's disease	0.000305	0.000315	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL2RA—Crohn's disease	0.000304	0.000314	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—ALB—Crohn's disease	0.0003	0.000311	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—CXCL8—Crohn's disease	0.000293	0.000303	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL2RA—Crohn's disease	0.000282	0.000292	CbGpPWpGaD
Tolazoline—ADRA2C—Metabolism—PTGS2—Crohn's disease	0.000263	0.000272	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—TYK2—Crohn's disease	0.000262	0.000271	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—JAK2—Crohn's disease	0.00025	0.000259	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—TYK2—Crohn's disease	0.000245	0.000253	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—ALB—Crohn's disease	0.000244	0.000252	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—JAK2—Crohn's disease	0.000233	0.000242	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—CXCL8—Crohn's disease	0.000228	0.000236	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—TYK2—Crohn's disease	0.000218	0.000226	CbGpPWpGaD
Tolazoline—HRH2—Signaling Pathways—IL6—Crohn's disease	0.000218	0.000225	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling by GPCR—IL6—Crohn's disease	0.000217	0.000224	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—TYK2—Crohn's disease	0.000214	0.000221	CbGpPWpGaD
Tolazoline—ADRA2A—Metabolism—PTGS2—Crohn's disease	0.000213	0.000221	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—CXCL8—Crohn's disease	0.000213	0.00022	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—JAK2—Crohn's disease	0.000208	0.000215	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—JAK2—Crohn's disease	0.000204	0.000211	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling by GPCR—IL6—Crohn's disease	0.000203	0.00021	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—TYK2—Crohn's disease	0.000199	0.000206	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—CXCL8—Crohn's disease	0.00019	0.000196	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—JAK2—Crohn's disease	0.00019	0.000196	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—CXCL8—Crohn's disease	0.000186	0.000193	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—STAT3—Crohn's disease	0.000183	0.00019	CbGpPWpGaD
Tolazoline—HRH1—Signaling by GPCR—IL6—Crohn's disease	0.00018	0.000187	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling by GPCR—IL6—Crohn's disease	0.000177	0.000183	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—CXCL8—Crohn's disease	0.000173	0.000179	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—STAT3—Crohn's disease	0.000171	0.000177	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling by GPCR—IL6—Crohn's disease	0.000164	0.00017	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—STAT3—Crohn's disease	0.000153	0.000158	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—STAT3—Crohn's disease	0.00015	0.000155	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—STAT3—Crohn's disease	0.000139	0.000144	CbGpPWpGaD
Tolazoline—ADRA2B—Signaling Pathways—IL6—Crohn's disease	0.000128	0.000133	CbGpPWpGaD
Tolazoline—ADRA2C—Signaling Pathways—IL6—Crohn's disease	0.00012	0.000124	CbGpPWpGaD
Tolazoline—HRH1—Signaling Pathways—IL6—Crohn's disease	0.000107	0.00011	CbGpPWpGaD
Tolazoline—ADRA1A—Signaling Pathways—IL6—Crohn's disease	0.000105	0.000108	CbGpPWpGaD
Tolazoline—ADRA2A—Signaling Pathways—IL6—Crohn's disease	9.72e-05	0.000101	CbGpPWpGaD
